Answers are grounded in this paper and cite their sources.
Advances in molecular genetics have transformed the understanding and recognition of developmental lung diseases (DevLD), a group of rare and heterogenous disorders arising from genetic alterations that disrupt pulmonary vascular, pulmonary parenchymal, and cardiopulmonary development. Among these, TBX4 variants have been identified as important developmental contributors to cardiopulmonary disease, due to their vital regulatory role in pulmonary morphogenesis and vascular development. Disruption of the TBX4 gene results in a wide spectrum of phenotypes ranging from persistent pulmonary hypertension of newborn (PPHN) to lethal developmental lung disorders or progressive pulmonary arterial hypertension, presenting later in life. This phenotypic heterogeneity highlights the complex interplay between disrupted lung development, pulmonary vascular remodeling, and cardiac adaptation. This review focuses on the cardiopulmonary interactions seen in TBX4 syndrome, particularly in infancy, highlighting key molecular and developmental mechanisms that underline currently appreciated genotype–phenotype interactions and current diagnostic approaches, with the goal of providing a comprehensive framework for understanding this increasingly recognized disorder.
No takes yet. Share an insight, caveat, or question.
Gopal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: